Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of ErbB receptors in pulmonary carcinoid tumors.
Rickman OB, Vohra PK, Sanyal B, Vrana JA, Aubry MC, Wigle DA, Thomas CF Jr. Rickman OB, et al. Clin Cancer Res. 2009 May 15;15(10):3315-24. doi: 10.1158/1078-0432.CCR-08-2549. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447869
ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation.
Kosari F, Ida CM, Aubry MC, Yang L, Kovtun IV, Klein JL, Li Y, Erdogan S, Tomaszek SC, Murphy SJ, Bolette LC, Kolbert CP, Yang P, Wigle DA, Vasmatzis G. Kosari F, et al. Among authors: wigle da. Oncogene. 2014 Jul 17;33(29):3776-83. doi: 10.1038/onc.2013.359. Epub 2013 Sep 16. Oncogene. 2014. PMID: 24037524 Free PMC article.
Generation and sequencing of pulmonary carcinoid tumor cell lines.
Asiedu MK, Thomas CF Jr, Tomaszek SC, Peikert T, Sanyal B, Sutor SL, Aubry MC, Li P, Wigle DA. Asiedu MK, et al. J Thorac Oncol. 2014 Dec;9(12):1763-71. doi: 10.1097/JTO.0000000000000339. J Thorac Oncol. 2014. PMID: 25226425 Free article.
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.
Mansfield AS, Murphy SJ, Harris FR, Robinson SI, Marks RS, Johnson SH, Smadbeck JB, Halling GC, Yi ES, Wigle D, Vasmatzis G, Jen J. Mansfield AS, et al. Among authors: wigle d. Ann Oncol. 2016 Nov;27(11):2111-2117. doi: 10.1093/annonc/mdw405. Epub 2016 Oct 14. Ann Oncol. 2016. PMID: 27742657 Free PMC article.
Management of Multifocal Lung Cancer: Results of a Survey.
Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS. Leventakos K, et al. Among authors: wigle d. J Thorac Oncol. 2017 Sep;12(9):1398-1402. doi: 10.1016/j.jtho.2017.05.013. Epub 2017 Jun 3. J Thorac Oncol. 2017. PMID: 28583587 Free PMC article.
FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery.
Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. Arnett AL, et al. Pract Radiat Oncol. 2017 Nov-Dec;7(6):e531-e541. doi: 10.1016/j.prro.2017.04.013. Epub 2017 Apr 19. Pract Radiat Oncol. 2017. PMID: 28733185 Clinical Trial.
385 results